0001214659-17-000579.txt : 20170131 0001214659-17-000579.hdr.sgml : 20170131 20170131210112 ACCESSION NUMBER: 0001214659-17-000579 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170128 FILED AS OF DATE: 20170131 DATE AS OF CHANGE: 20170131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Varex Imaging Corp CENTRAL INDEX KEY: 0001681622 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC COMPONENTS, NEC [3679] IRS NUMBER: 813434516 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 1678 S. PIONEER ROAD CITY: SALT LAKE CITY STATE: UT ZIP: 84104 BUSINESS PHONE: 800-432-4422 MAIL ADDRESS: STREET 1: 1678 S. PIONEER ROAD CITY: SALT LAKE CITY STATE: UT ZIP: 84104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SANYAL SUNNY CENTRAL INDEX KEY: 0001599398 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37860 FILM NUMBER: 17562830 MAIL ADDRESS: STREET 1: VARIAN MEDICAL SYSTEMS INC STREET 2: 3100 HANSEN WAY MAIL STOP E327 CITY: PALO ALTO STATE: CA ZIP: 95035 4 1 marketforms-37686.xml PRIMARY DOCUMENT X0306 4 2017-01-28 0001681622 Varex Imaging Corp VREX 0001599398 SANYAL SUNNY C/O VAREX IMAGING CORP. 1678 S. PIONEER ROAD SALT LAKE CITY UT 84104 true true false false President and CEO Non-Qualified Stock Option (right to buy) 2017-01-28 4 A false 0 0 A 2021-02-21 Common Stock 0 D Non-Qualified Stock Option (right to buy) 2017-01-28 4 A false 0 0 A 2022-02-13 Common Stock 0 D Non-Qualified Stock Option (right to buy) 2017-01-28 4 A false 0 0 A 2023-02-12 Common Stock 0 D Restricted Stock Units 2017-01-28 4 A false 0 0 A Common Stock 0 D Restricted Stock Units 2017-01-28 4 A false 0 0 A Common Stock 0 D Restricted Stock Units 2017-01-28 4 A false 0 0 A Common Stock 0 D In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 21, 2014 and the remaining vests monthly thereafter. Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 13, 2015 and the remaining vests monthly thereafter. Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 12, 2016 and the remaining vests monthly thereafter. In connection with the Spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. These RSUs vest February 21, 2017. Vested shares will be delivered to the reporting person upon vest date. These RSUs vest in two equal annual installments beginning on February 13, 2017. Vested shares will be delivered to the reporting person upon vest date. These RSUs vest in three equal annual installments beginning on February 12, 2017. Vested shares will be delivered to the reporting person upon vest date. /s/ Kimberly E. Honeysett, Attorney-in-fact 2017-01-31 EX-24 2 poa.htm POA DOCUMENT

      Power of Attorney

I, Sunny S. Sanyal, hereby constitute and appoint Clarence R. Verhoef, Matthew
C. Lowell, Kimberley E. Honeysett, Keith K. Facer and Stephanie D. Reid, and
each of them individually, as my true and lawful attorney-in-fact to:

1.	Prepare, execute in my name and on my behalf, and submit to the U.S.
Securities and Exchange Commission (the "SEC") a Form ID, including amendments
thereto, and any other documents necessary or appropriate to obtain codes and
passwords enabling me to make electronic filings with the SEC of reports
required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or
regulation of the SEC.

2.	Complete and execute on my behalf as an officer and/or director of Varex
Imaging Corporation (the "Company") any Forms 3, 4, or 5, and any amendment
thereto, required to be filed by me under Section 16(a) of the Securities
Exchange Act of 1934 and the rules and regulations thereunder.

3.	Do and perform any and all acts for and on my behalf which may be necessary
or desirable to complete any such Form 3, 4 or 5, and any amendment thereto, and
timely file such form or amended form with the SEC and any stock exchange or
similar authority; and

4.	Take any other action of any type whatsoever in connection with the
foregoing, which in the opinion of such attorney-in-fact may be of benefit to,
in the best interest of, or legally required of me, it being understood that the
documents executed by such attorney-in-fact on my behalf pursuant to this Power
of Attorney shall be in such form and shall contain such information as such
attorney-in-fact may approve in such attorney-in-fact's discretion.

I hereby grant to each of such attorneys-in-fact full power and authority to do
and perform any and every act which is necessary or desirable to be done in the
exercise of any of the powers and authority granted in this Power of Attorney,
with full power of substitution and revocation, and I ratify and confirm every
act that such attorney-in-fact lawfully performs or causes to be done by virtue
of this Power of Attorney and the powers and authority granted herein.

I acknowledge that the attorneys-in-fact appointed in this Power of Attorney, in
serving in such capacity at my request, are not assuming, and the Company is not
assuming, any of my responsibilities to comply with Section 16 of the Securities
and Exchange Act of 1934 or the rules or regulations thereunder.

This Power of Attorney shall remain in full force and effect until I am no
longer required to file Forms 3, 4 or 5 with respect to my holding or
transactions in securities issued by the Company, unless I earlier revoke this
Power of Attorney in a signed writing delivered to the foregoing
attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has executed this power of attorney as of
this 3rd day of November, 2016 at Salt Lake City.


						/s/ Sunny S. Sanyal
						Sunny S. Sanyal